Quality of life and comorbid anxiety disorder in persons with schizophrenia, schizo-affective and bipolar affective disorder under remission

Journal Title: IOSR Journal of Pharmacy (IOSRPHR) - Year 2015, Vol 5, Issue 8

Abstract

 BACKGROUND: Quality of life is considered in clinical psychiatry as an intermediate and distal outcome in the management of major mental disorders. Anxiety disorder is the commonest mental disorder which can be identified easily and can be treated easily. Treating co-morbid Anxiety disorders has multiple benefits of improving quality of life, reducing distress to the patient and family, and performance of the patient. AIM: To assess the quality of life and comorbid anxiety disorder in persons with schizophrenia, schizoaffective and bipolar affective disorder under remission. METHODS: Patients attending for review at Institute of Mental Health (IMH), Hyderabad, diagnosed with schizophrenia, schizoaffective disorder and bipolar affective disorder according to ICD-10 in the past and currently on treatment were all considered. Tools administered included - Mini international neuropsychiatric interview (MINI) to ascertain any other axis I diagnosis; Hamilton anxiety rating scale (HAM–A) to know the severity of anxiety symptoms and WHO QOL – BREF for assessing the quality of life RESULTS : The mean physical health, psychological, social, and environmental domain of WHOQOL-BREF scale scores in schizophrenia, bipolar group and schizoaffective groups were found to be significant. HAM-A mean scores of schizophrenia group, bipolar group and schizoaffective group were 7.23, 7.83 & 5.23 respectively. CONCLUSION In the present study sample, Schizophrenia group scored the highest on WHOQOL-BREF scale while bipolar scored the least. However there was no significant difference among three groups when compared. The most commonly reported anxiety symptoms on HAM-A scale was anxious mood and cardiovascular symptoms. There was no significant difference of anxiety levels among the three groups. In future, studies must be carried out on patients under remission over a period of time, preferably from a sample in the community

Authors and Affiliations

Dr. Vivaswan Boorla* , Dr. Siva Prasad Kasimahanti M. D (Psy)

Keywords

Related Articles

 Evaluation of Goat Fat as Potential Co-Lubricant in Pharmaceutical Tablet Dosage Form

  In this study, goat fat co-processed with a combination of magnesium stearate and talc (GMT) was evaluated as a lubricant and compared with magnesium stearate plus talc (MT) and without lubricant using flow o...

 In-vitro Antioxidant and Antimicrobial Activities of Some Medicinal Plants grown in Western Ghats of India

 The aim of the study was to evaluate medicinal potential of five mostly used plants from Western Ghats of India. Methanolic, aqueous and ethylaceate extracts of the plant species were screened for its total pheno...

Effect of Probiotic Lactobacillus plantarum (NCDC LP20) on Enhanced Innate Immunological Indices of Freshwater Fish.

In according to several reports, the advantageous effects of bacteria on fish have well been documented. Probiotics as an alternative strategy have been suggested to be used as reinstatement for antimicrobial drugs and g...

Heavy Metal Pollution Induced Histopathological Changes in Anabas testudineus collected from Periyar River at Ernakulam district and the Recovery Responses in Pollution free water.

Heavy metal (lead, nickel, zinc, arsenic and cadmium) pollution status in water, sediment and the corresponding bioaccumulation in biomass of Anabas testudineus from two different stations of Periyarriver at Ernakulam di...

Download PDF file
  • EP ID EP148371
  • DOI -
  • Views 82
  • Downloads 0

How To Cite

Dr. Vivaswan Boorla*, Dr. Siva Prasad Kasimahanti M. D (Psy) (2015).  Quality of life and comorbid anxiety disorder in persons with schizophrenia, schizo-affective and bipolar affective disorder under remission. IOSR Journal of Pharmacy (IOSRPHR), 5(8), 23-30. https://europub.co.uk./articles/-A-148371